MM+M summer intern Molly Huth, ‘a natural behind the mic,’ says goodbye

Hey, it’s Marc This week we bid farewell to a member of MM+M’s editorial team – summer intern Molly Huth. Molly came to MM+M in June as a third-year English lit and human rights studies student at University of Dayton. And since then, she’s made a solid contribution to the new desk, compiling our “5 Things for Pharma Marketers to Know” daily update and reporting on everything from pharma corporate earnings to the health-oriented storylines of Olympic athletes like Suni Lee. Also impressive is how she’s added her voice to the weekly podcast, winning us over with her easy going demeanor and ability to discuss current events through a health-marketing lens. But she’ll face one more test: an exit interview with her editorial teammates on this week’s show. And for our weekly Trend segment, we’ll tackle Kamala Harris’ choice of Minnesota governor Tim Walz as running mate and what we know about his healthcare policy history, as well as new revelations regarding Lykos Therapeutics’ negative but interesting psychedelic AdCom discussion for its MDMA-assisted therapy. Awesome. Well, Molly I’m going to start off with a fairly easy question because I have a number of them in front of me. But let’s just go with how are you doing? I’m great. Yeah having a good day, you know got the intern presentation this morning well and Yeah, I’m glad to be here. So talk to us a little bit about that before we get into your entire internship experience. I know this started from when you joined us to where you are right now. What was this project? Yeah, so they pitched it to us day one. So it was basically our entire group. I think they’re like 20 of us about we were up into four different subgroups and we are tasked with the mission of just making a Psychiatry advisor award ceremony. So I was in the content group. So I was just coming up with Awards and kind of key opinion leaders doing some internet stocking on the big names in the industry. And yeah, we compiled it all together today. It was really great to see it all come together after you know how eight weeks of working on it and emailing about it and media about it. Were you nervous? I was really nervous like even when I got up there I was like, oh I can’t breathe but it went well, that’s all. Yes. Let’s start with just kind of a Cap on your experience you you were working on that internship project you were working for us in terms of writing stuff for the website interviews. You were also doing work with the medical advertising Hall of Fame talk to us a little bit about the stuff with medical advertising Hall of Fame. I know you had alluded to it in earlier episodes, but now you’re in your final week and handing it off Yeah. So basically they’re looking to make another addition just an updated version of the last I think he’s going back to 2010 of just kind of the best of the best and so I went through all the mmm Wars we had to do some digging some going back to old paper copies from like 2010. Thanks to Kevin shout out Kevin. But yeah, so he basically just compiled they they chose a couple of different categories that they wanted to focus on and we listed, you know, the company name the people who made the whatever it may have been and then just either the product launch or whatever it was that they’re being on for. Very cool. I’m curious what you’ve learned. This is an industry that admittedly I didn’t know a ton about when I first came over here and I’ve leaned on Mark considerably because he has so much industry experience and knowledge for you what has been some of the biggest learnings from you know, is it been watching TV differently where you’re like, oh that’s a pharmaceutical ad or is it something about the way they’re putting together these campaigns what really sticks out to you? Yeah, I think All of that. I mean when I’m watching TV, I’m like, oh my God, I know that company. Um, or I’ll be like, oh that drug. I just wrote about that. Um, but yeah, I came into it really only knowing the extent of my knowledge was from watching dope sick and so not a great impression of the Pharma industry, but you know, I’ve learned a ton and it’s really it’s made me very optimistic about just like I’m anxious person. I’m always like what if I’m I’m always a hypochondriac it’s nice to know that people are working towards some really amazing things. And yeah, I’ve just I never really I always knew it was a massive industry, but I didn’t understand especially until I was doing the financial reports and stuff like that for the second quarter of this year. Just how much money is in these companies. I was even telling my dad and he was like wait that’s their market cap as like, yeah, it’s not crazy. But um, it was really cool and I I learned a lot and even just with the Olympics too. I didn’t really Is you know the kind of international stage that companies had like Eli Lilly and all of them? Yeah. It was really cool. Awesome Mark. I want to bring you in here in case you have any sort of questions. I have a few other ones written down but want to bring you in I appreciate that. Yeah. Yeah. I was really impressed. You know that you’ve already in your short time here already amassed five pages and the mmm Archive of your stories, you know, as you said everything from the financial learning to the Olympic coverage, but you also did some you know Straight Ahead marketing coverage and you know, this is a B2B, you know where you’re not reporting for, you know, a mainstream, you know, you’re kind of looking at it through a particular lens, but I wanted to you know asked you how you were able to kind of, you know adapt that lens. So so quickly, you know, how do you find that you know making that adjustment? Yeah, and I mean the five pages that’s like a jack shout-out Jack for just give me a assignments but it was definitely an adjustment just with I didn’t really understand the audience the same way. I feel like I needed to do a lot of digging. I remember on that first day. I spent most of the day first probably two days just reading. Mmm articles trying to understand Googling different companies. And I think that’s right when our our agency 100 dropped so I got a good briefing just on like the big names by reading through all those but it was definitely an adjustment just with I think interviewing people helped. So for a couple of those articles, like you said the ones that were just about marketing campaigns and stuff like that. I got to talk to the people who were behind it. Which also just helped with like Skills of you know being able to speak to somebody over, you know Zoom can be a little awkward but I really learned a lot from those experiences and just kind of one of the people said like it’s a very niche market and I think that’s true but it is like you don’t realize how important it is. So that was really cool. Right? So aside from that sort of Greater appreciation of the industry that you got from kind of being an Insider a little bit. Would you say like your friends, you know and people you know younger people in their 20s or you know college age some you know, what other people in your peer group feel about the industry and kind of like you think that there are so kind of like that’s the extent of their knowledge is kind of what they see on on, you know, the trending, you know, mini-series or whatever on on Netflix or something. You know, what would you kind of tell them, you know, if you were at a cocktail party now that you’ve gotten this, you know greater understanding. Yeah, I think I would tell them you know, it’s more than ozempic. It’s more than just the that was the big thing that we all knew about from tiktok and stuff. And I think I would just tell them like it’s worth looking into I think there’s a lot of my friends are, you know, definitely the people who are getting all their information from tiktok they’re going on there and they’re finding these like when I wrote I wrote like a medical misinformation piece on tiktok and my friend was like, oh my god. I’ve been doing some of those things. So I was like, she’s been like sleep tape like taping or face when she’s sleeping. I was surprised but also I wasn’t I think a lot of them do have a little bit of a almost weariness when it comes to drugs and stuff like that just from like our exposures really dope sick and kind of stuff like that and you see all these like horror stories on tiktok and it just kind of blossoms, but I think I would tell them it’s worth looking into it’s a huge industry and they are doing a lot Of good, there’s definitely some flaws but they’re really, you know, trying to better people’s lives and ideally so are the marketers they’re trying to really out like find the people who need help and can benefit from these drugs. I just want to hop in there because I think Molly underscores a really important thing and I know that in the trend segment, we’ve talked about face taping and vampire teeth and all these sorts of things. I know that sometimes we have a laugh about it or I’ve even heard from people like, you know, why talk about that on the show or why give that coverage and it’s like, okay so it might not be your cohort. It might be if you’re in the industry or if you’re an older generation or something, but you are gen Z. It’s the first time I’ve ever felt old in my working career is somebody that is that much younger than me, but you come with a different media consumption a different way that you view things and that’s been very insightful. I don’t know about you but it’s been very insightful for me seeing like oh, this is how I consume or view the world but there is another generation that has a whole different way and if you don’t communicate and understand their Needs appropriately then that’s where the disconnect and that’s where misinformation all these other sorts of History issues can still proliferate. Yeah, and I think with that and stuff. I mean a lot of my friends have these it’s even with like Advil and stuff. So they’ll be like, oh, I don’t want to take too much medication or something like that. I’m not like a pill Pusher but I’m like if you have a migraine taken Advil, but I think there is just this mistrust and just lack of understanding. It really comes down to just not knowing and that’s why I think it’s important to talk about this, you know misinformation and yeah, we’re giving me a platform but we’re giving in a bad platform, you know, we’re proving that it’s not accurate so that when somebody because people are seeing these videos and if you just ignore it, it’s just going to perpetuate it. So absolutely I wanted to ask you Molly because last Mark said five pages worth of stories. I think that’s more than most interns probably get in and you’re going back into the world with a lot of Clips, which I’m excited about what are some of the stories that you are the proudest of the ones that you even Enjoy the most and you’ve gone to different Live Events too both with me Lesha on your own. You know, what stands out from your coverage? Yeah. I think I mean I really did like that story last week about the pommel horse guy. That was just fun just being able to kind of freely write a little bit more because some of them each one. I feel like has a different tone and style which was something that was huge to learn through this. I did find by the end of it. I was really like Satisfied by some of the financial reports for just like getting and I was like, okay, I think I got everything it was like nice and organized or Lack of a better term. But yeah, I think the pommel worst guy story is really fun to write. So you need just cuz I love her big seemingly fan and then I wrote the medical and misinformation story. It was one of my first weeks. I think it might have been my first week, but that was just really cool to kind of tie in like my generation and talk about tiktok. And it’s it’s plays such a big role in all like my life and in my friends lives whether we like it or not. So it was cool to be able to kind of like delve deeper into that and then as for events, I mean I got to go some some really cool stuff. I got to go with Lasha to this event at her house tower which by the way has the coolest view of Central Park from above I was looking up there. I was like, oh my god, I’ve made it pretend it was my corner office, but it was really really interesting. It was the mine Labs event and it’s amazing speakers. Ashlyn Harris teffy post a tiktoker. She was really funny and it was really cool to hear their different perspectives coming from like an athlete and mental health and going into the Olympics. It was cool to have that background where she had talked about how it’s like managing this pressure and handling it. And then there’s been a lot of talk about it with you know, Simone biles and you just see it in these people these athletes faces when they you know, accomplish something how much it weighs on them, I guess. But then it was all really interesting. There were a lot of magazine editors there. So like the editor of Men’s Health Women’s Health Good Housekeeping and Oprah Magazine, we’re all speakers and that was just really interesting to just hear more from like this industry and kind of like get even more information and insight and one of the interviewers was the editor of Cosmopolitan and she was like in her like 30s like very funny and just excited to be there and it was like infectious and She interviewed Tuffy post on that was really really just a funny light-hearted but also deep and insightful conversation about, you know, just regular people and their mental health. Yeah. It’s really interesting you talk about that Molly. I think you were calling back to the dark ages of when I first joined mmm. I think the prevailing issue then was the Ties between industry and medicine and the fact that you know, we needed to create distance between industry and its undue influence on the practice of medicine, you know, whether that played out and continuing medical education and the funding of that or other areas that was kind of like a big theme of the mid pots and now, you know fast forward more than a decade and a half here almost two decades and it’s really influencers and I think and you know, the power of influencers even though they’ve been around you and they started as patient ambassadors, I guess back in 2014 or so that was kind of the term that was used, you know disease awareness disease State ambassadors and we saw the growth of networks, you know, like, you know health union and those kinds of networks of health health influencers, and now with kind of like, you know, the tiktok crowd and people kind of developing their own brand and forging their own. Ties with with industry in some cases are just being independent which precipitated the recent FDA guidance that we saw, you know, replacing the 2014 guidance on how to correct misinformation. Often arising from these independent influencers and I think the power of health of patient influencers is really about to be Unleashed in a big way where we’re starting to see that Studies have shown that the trust that they engender with audiences carries over into a Pharma companies brand advertising and can really help not only stimulate awareness, you know for products, but can result in increased demand for products. And so I think we’re on the cusp of something really big there and you’ve kind of hit on that, you know in your coverage. Does that a trend that you what do you foresee happening there, you know kind of that you since you have a kind of a good feel for those jackpot you’re in gen Z, you know your firmly in that world that is comfortable that grow up with social media and it’s comfortable, you know sifting through what you see on tiktok. What do you foresee for that industry or the next 18 months? I think it’s really interesting. How like I feel like through this job. I’ve seen a lot of how it shifted like I knew how it was present day. A lot of people, you know, listen to influencers and stuff but going through the maahs stuff and kind of seeing the past how it was, you know, even how the awards changed it would be. Like it also was more electronic like data and analytics and then it was shifting to social media use and TV and it just it is cool to see out of all over time. I do think there is something kind of unique with Jen gen Z just where a lot of They kind of they’re there’s a level of straightforwardness or bluntness where people are just willing to share pretty much everything to a false at times. But I do think it’s a good way to you know, create these conversations and I think social media is really where that happens. It would be interesting to just like the way that AI plays into it all and in the future just seeing like how AI shifts this industry and its self but like social media is just here to stay don’t and don’t see that going anywhere. I am curious to see like what the new social media will be because I feel like you know it Facebook is at this point for us. At least it’s kind of like do you even have it on your phone? And then, you know a little bit more of Twitter Instagram, but everybody’s just on tiktok and that was you know, the last couple years so should be cool to see if another one emerges or how that goes, right? Oh, yeah. I think I think we have some people in our audience that would pay very good to mine your in your generation’s. Its brains media consumption. I’m sure there are people there. They’re like, wait a second. They’re not on Facebook anymore. Like they don’t even have another phone but that’s for a whole different conversation. We’ve talked a lot about your experience here with covering the industry and learning a bunch of stuff. I wanted to focus back on to you for a second. So you’re going into your senior year. What are you looking forward to when you go back to Ohio? Yeah. I mean first things first. I leave a week from today. I’m really excited to see all my friends, of course and also just I have some really great classes coming up this semester. It’s my senior year. So I kind of like a little bit more flexibility with what I got to pick. So I have a couple that I’m taking detective fiction which will be really cool and film folklore and fairy tales very curious. But yeah, so I have an exciting academic roster and then just being able to be back with my friends and have a full year. Just kind of embracing The joy of college one last time and you know making the most of it and really really excited. I’ve got a house with six my best friends and we bring all of our neighbors or our other friends. So it’s just gonna be a really great Year enjoy that it’s great. I’m not gonna speak on behalf of Mark or fits here, but I can say only for my own experience of living in a house with not seven. I had seven other people but that senior year is definitely one of those times. I look back on fondly and I wish the best for you when it comes to post-grad. So you’ve now had this introduction to journalism and what we do, I think that journalism, you know, I I say, this is somebody that majored in it has made a career out of it does give you a bunch of different opportunities in terms of writing editing Communications marketing you name it. Is there anything that you’re looking at Postcard? I know it’s almost a year away at this point. Is there anything that you’re looking at? You’re like, oh, maybe this is something I’d like to do or where do you see your career path going? Yeah. I really have enjoyed. I mean, I hadn’t thought a lot about journals until this job. Really just because I didn’t like I I wasn’t on the student paper or anything like that. So it was really just a lack of exposure and I’ve really enjoyed it. I’ve really enjoyed, you know getting to write stuff. I find it very fulfilling and it’s very like I like the deadlines and being able to kind of turn it over and get it in and I also think it’s a great way to just stay up to date. Like I’ve I’ve been checking the newspaper every day. But so I do see that in my I could definitely see myself pursuing that or I love books always loved books. It would be a dream to work and any kind of publishing or anything surrounding books and writing even just I could see myself in the distant future after you know years of corporate America becoming like a high school English teacher. I really would love to share that and yeah, I’m excited though. Got a couple of good. I do ideas I guess and we’ll see where it goes. That’s all you need at this age. And for anybody in our audience that is connected in the publishing. Industry. Yeah, maybe this be a recommendation from marking myself. Molly is for the taking Molly up before we go into the trend segment. It’s been wonderful having you as an intern and we’ve been able to see you grow and contribute to the team in a real like you said fulfilling way. It’s really improved our coverage and I think you personally on that for let’s say next year when we have our next Molly. If there’s somebody that’s interested in interning at Haymarket, it’s not really just with mmm, but like you’ve got to interact with what is it like two dozen other India. So we have here what sort of advice would you give to them in terms of like hey, this is what the culture is like or this is what the expectations are. What if somebody said I’m an intern or I want to intern at Haymarket. What would you say to them? Yeah. I mean a lot of my friends from school also have internships and it is unique the just the you guys really accept the interns into the atmosphere very, well. I always kind of felt like I was a part of the team which is really impressive and a great feeling when you’re working somewhere. I would say if you know, hey markets are really great place to enter or not. They have that great. We touched on it earlier the internship project that goes throughout but I also do feel like I am just being in the office being around people and a corporate setting. I’d never done that before big change from waitressing, but it’s just it really is a great learning opportunity. I’ve come out of this with more than I ever. Thought I would I didn’t really know exactly what I was kind of getting into. Yeah, I knew what Stephen told me but it’s exceeded my expectations exponentially. Yeah, and if you do end up interning at Haymarket, I would just say reach out to people and take in every second of it whether it be like if you’re in mmm, or if you’re writing articles just going back to you really gonna just showing me like what I was doing right what I was doing wrong and just kind of trying to improve and yeah, it was really amazing. Awesome man. Well, I’m glad that this experience did live up and exceeded those expectations. We wanted to be able to have you you know, whether it was covering a campaign or going to a live event or I know those fine. I’ve done those financial briefs for years and years or not. They’re not the most fun thing to do but there is a value in saying oh I got all the right information and you’re able to put it out there. So again, I appreciate you being a part of the team and being game for anything. That’s not always a given with Turns and hopefully that’s something that we excel at here at Haymarket media trending that brings an end to our exit interview segment here. We’ll go into our Trends and just a couple hours before we were set to record this we were going to talk primarily about the Trump healthcare plans that are in agenda 47, but then Kamala Harris vice president announced a Minnesota Governor Tim. Walz as her running mate, that’s per a bunch of news reports by the time that you’re listening to this are audience. They will have already had their opening rally in Philadelphia walls had emerged alongside Josh Shapiro, the governor of Pennsylvania and Arizona Senator Mark Kelly is the finalists and ultimately he won out there’s a lot to unpack in terms of walls Healthcare track record. There’s his defending of abortion access, especially since he was reelected in 2022 as well as gender affirming care his thoughts on the national covid-19 response. He’s been very Progressive on a number of Health Care issues Supported medical research of cannabis and the legalization of recreational cannabis in the state extended Veterans Affairs studies on the effects of Agent Orange. He was also a member of the National Guard and there is also some issues in terms of you know, how Progressive he’s going to be versus what was an earlier conservative record Mark. I want to bring you into the conversation. There’s not we have had a ton of time to really unpack Tim. Walz as the healthcare giant, but what’s your initial read? It’s kind of like a JD Vance situation in we have a Midwestern guy with not a ton to give us on the healthcare side. But at least some breadcrumbs. Yes, some breadcrumbs good way to put it to Specialty, you know in the area of Reproductive Rights. He was called somebody who’s so pro-choice. He said that Nancy Pelosi had asked him to tone it down. He’s kind of in the plan Parenthood Camp. He was giving when he was in the House of Representatives from 2007 to 2019. He was giving a 0% pro-life score from the national right to life. And if you look at his voting history there and as governor and 2023 January 2023, he signed a measure that effectively removed all restrictions on abortions and Republican lawmakers said that law would allow for abortions in any stage of pregnancy. So there’s no doubt about his Bona fides when it comes to, you know, protecting women’s Reproductive Rights. So that kind of aligns him with Kamala Harris’s stance, which I think I would argue is the thing that we know most about her in terms of a healthy standpoint. And I think a lot of people are waiting to hear more details. She hasn’t really sat for any kind of substance of interview in the last two weeks since she became the presumptive Democratic nominee. Yeah, and another thing just to add to Tim. Walz is Healthcare track record is that he did vote in favor of Medicare drug price negotiations when he was in the House of Representatives. So obviously that’s something that’s come to the four just bring in the other side of things too. There’s been a lot of speculation talk in the media about project 2025 and whether or not that would be kind of this conservative wish list for policies. If former president Trump is elected back to the White House. He is he in the campaign of distance himself from that and they’ve put out agenda 47 which is kind of their own wish list in terms of this is what we’re going to do the USA Today did a great breakdown will link to it in the show notes here, but they just did a rundown of like here the things that are actually important in healthcare wise especially for for our audience to say the farmer Community. There is the promise to bring back pharmaceutical production to the US that was something that is listed in agenda 47. There’s also getting tougher on Farmers Google companies Market, I think. I talked about this. It’s not last week’s episode the one before where I don’t think Farmers really gonna find much of an ally whether or not you get a Harris or Trump a second Trump Administration. It seems like they’re going to be faced between a rock and a hard place. There will be interesting to see how they Lobby on that and then there was talk from Trump about eradicating the drug addiction crisis in America. I know that’s something that the Harris campaign is also focused on too with different approaches. I think there’s a more aggressive line. You would say from the Trump Administration. There’s talk of cracking down on drug cartels imposing the death penalty on drug dealers threatening China with exporting fentanyl like there. There’s a lot more there. That’s more I would say Aggressive but it gives us a glimpse too. And to now that we have these four people Trump advance and then Harrison walls. This is kind of where the the healthcare industry has to make their bones policy wise, right? Yeah the sort of know that they’re up against either Administration would not be allies, you know, in terms of the drug pricing agenda. I think they would keep up the pressure. You know, some people may recall that Kamala Harris was the deciding vote in Congress, you know, when the IRA was up for a vote and it was a split 50/50. She was the decisive vote that got that through and that’s one of the Biden policy achievements that she is, you know taking credit for to what extent you know, she was involved. We don’t know but she will, you know sort of count that among her Bonafide he’s moving forward and she giving her, you know, everything we know about her agenda. She will probably, you know continue to push. There and Trump, you know, when he was in office, you know, he was famous for saying that, you know, the drug companies are quote unquote killing people, you know with their high prices, but he was not able to you know, effectively, you know, push through much, you know, as effective as the IRA was and kind of introducing drug price negotiation. I think what we’ll need to keep an eye on you know is and this is more of a concern with a Kamala Harris president see is you know, and I think the farm industry really fears this from an existential point of view, whether they’re going to use the IRA to kind of really expand, you know, as a platform, you know to to expand the reach of drug price negotiation beyond the remit that it currently is called for in the current legislation. I think nobody, you know, people really want to stem stem the bleeding from that so to speak I don’t know if the fear is so is quite as acute, you know with a trump president is it would be you know from a Harris one? Yeah. It’s interesting you bring that up too because we’ve been obviously Molly and I’ve been following these quarterly. Ranks reports and there have been a number of companies the ones that are more front-facing with the IRA saying like, oh we expect to have this sort of damage or we’ve gotten the Final prices, but they expect a limit it so it’s it’s interesting kind of the talking out of both sides of your mouth where it’s like, oh no, we expect this to be really harmful to our bottom line by the same time. They’ve already calculated how much that’s really gonna hamper them from a financial perspective. So that’s interesting one other note. I’m going to make just in terms of the healthcare record. I don’t think that we’re going to see another HHS secretary if Trump gets elected who used to work for Eli Lilly. I think those days are probably gone just from the messaging and the and the Optics that we’ve seen there and one final thing too. I said earlier that the healthcare industry is faced with two choices between Harrison and Trump. I don’t want to overlook the fact that yes RFK Jr. Is still in the race. We didn’t have enough time in this week’s pod to talk about hiding a dead bear cub in Central Park. So my apologies there for anybody who was missing that I want to move on to our last story here, which is the Wall Street Journal has had a deeper dive into the light Coast Therapeutics MDMA trial Mark curious your thoughts. This is a pretty expansive rundown. We don’t have to give you know, the highlights to our audience will link to it in the show notes by hasn’t read it already but it’s just another lump on like ghosts and it seems troubling if nothing else in terms of how they’ve how this reporting has gone about this. Yeah, another lump on lycos well said, you know basically back in June 5th. We saw the results of the advisory committee meeting for lycos Therapeutics MDMA assisted therapy and was more negative than expected. Even with unfavorable voting results The Briefing documents that had been released May 31st kind of telegraph that but some of the problems there that they were focusing on was the functional unblinding and expectation bias durability of effects of psychotherapy the risk assessment as well as a proposed Rems program and you know to put it I think mildly, you know, it’s unlikely that the light goes MDMA assisted therapy is going to be approved on August 11th, which was the Paducah data originally set for that. And this was for treating PTSD it PTSD, excuse me, and the lot of these concerns had been surfaced. Is a report and as I mentioned the FDA briefing documents, so I think the street, you know, in terms of, you know, a read through just to other companies in the Psychedelic space. There’s other companies that are pursuing PTSD therapies with you know, MDMA and people are saying that the read through is limited, you know, and and that the, you know, the psychedelics space still has potential, you know, great potential despite the shortcomings here and I encourage readers to delve into the wsj deep dive themselves, but it gives a good obviously, you know, they took the I think what came out of the briefing documents and they Did some interviews with some of the trial subjects and there was some really serious impropriety going on there between the subjects and one of the therapists, you know lycos to their you know for their part, you know has has denied that there was you know and proprieties going on here. But and then they stand behind the data but you know, the street is not looking favorably toward this August 11th Paducah date. But again the read through to the Psychedelic space in general is limited. Yeah, it’s one of those things too where you know what this means just like that was going forward. I think a lot of people are gonna be watching what happens in the next week with great interest. I would just say this that you know, we cover a lot of different trials that you know, don’t meet their expectation or their side effects and companies have to Wrangle with that. There is something that’s a little bit different when it’s dealing with subject of mental health and suicide and I think that’s kind of what elevates it too. Like the fact that the Wall Street Journal here has Interviews with trial subjects who are saying the treatments brought back memories of traumatic events in their life. And this is supposed to be a treatment that’s supposed to remedy that or mitigate that damage is something that is very troubling I think for anybody that’s involved whether you’re in the industry or watching from afar so definitely something will follow with with interest going forward, but it’s it’s certainly topping news and our industry. So it’s worth delving into a little bit there. Like I said, well include a link in the show notes in case anyone hasn’t read it but I think with that we’re good Molly. Thank you for thank you guys for having your insights. Do you want to read I know we usually throw this to Mark to say thank you, but you want to get us on that last one of a preview for the podcast next week. Sure. Thanks for joining us on this week’s episode of the mmm podcast. Be sure to listen to next week’s episode when we joined by Raja Haddad Chief marketing officer at Primo. Oh, that’s it for this week. The mmm podcast is produced by Bill Fitzpatrick Gordon. Our theme music is by Susie himself rate review and follow every episode wherever you listen to podcasts new episodes every week and be sure to check out our website and then hyphen online.com for the top news stories and farmer marketing.